Breast cancer, Secondary cancers
Results
Phase 3
This trial looked at capecitabine with or without vinflunine for breast cancer that had come back after other treatment.
The trial was open for people to join between 2009 and 2011. The team published the results in 2018.
Recruitment start: 6 May 2009
Recruitment end: 25 May 2011
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Mary O’Brien
NIHR Clinical Research Network: Cancer
Pierre Fabre Medicament
Last reviewed: 21 Sept 2023
CRUK internal database number: 4230